Marinus Pharmaceuticals is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological and psychiatric disorders.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/07/13 | $21,000,000 | Series C |
Canaan Partners Domain Associates Flare Capital Partners RusnanoMedInvest Sofinnova Ventures | undisclosed |
